SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS

The present disclosure relates generally to certain 6-azabenzimidazole compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions disclosed herein may be used for the treatment or pr...

Full description

Saved in:
Bibliographic Details
Main Authors Lo, Jennifer R, Chandrasekhar, Jayaraman, Kim, Musong, Salvo, Patrick J, Codelli, Julian A, Perry, Thao D, Loyer-Drew, Jennifer A, Bartlett, Mark J, Kasun, Zachary A, Zablocki, Jeff, Mitchell, Scott A, Lee, Seung H, Balan, Gayatri, Van Veldhuizen, Joshua J, Cosman Ellis, Jennifer L, Kalla, Rao V, Yeung, Suet C, Phillips, Gary B, Conway, John H, Swaminathan, Sundaramoorthi
Format Patent
LanguageEnglish
Published 29.08.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates generally to certain 6-azabenzimidazole compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions disclosed herein may be used for the treatment or prevention of diseases, disorders, or infections modifiable by hematopoietic progenitor kinase 1 (HPK1) inhibitors, such as HBV, HIV, cancer, and/or a hyper-proliferative disease.
Bibliography:Application Number: US202318543272